NAGE
Niagen Bioscience
$3.23
+$0.02 (+0.62%)Jul 27, 2026
Key metrics
The numbers that frame NAGE today
- Market cap
- $257.25M
- P/E (TTM)
- 13.8
- EV / FCF
- 47.1
- Gross margin
- 64.3%
- EV / Sales
- 1.5
- ROIC
- 118.3%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $3.12
- 52wk High
- $11.29
Growth
Revenue and earnings trend for NAGE
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about NAGE
Is Niagen Bioscience a good buy?
No. Niagen Bioscience has weak quality and poor momentum. Both signals point to a weaker setup. Growth looks weak. That could put pressure on the long-term business case. We think Niagen Bioscience is selling at a low price, but price alone does not change the weak overall picture.
What is the market capitalization of NAGE?
Niagen Bioscience's market capitalization is $257.25M.
What is the P/E ratio for NAGE stock?
Niagen Bioscience's current P/E ratio is 13.8.
What is the 52-week high for NAGE stock?
The 52-week high for Niagen Bioscience is $11.29. The current close of $3.23 is 71.4% below that high.
What is the 52-week low for NAGE stock?
The 52-week low for Niagen Bioscience is $3.12. The current close of $3.23 is 3.5% above that low.
Does NAGE stock pay dividends?
Niagen Bioscience does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for NAGE?
Niagen Bioscience's Debt / Equity ratio is 0.03.